Autobahn Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Autobahn Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults (NCT06869187) | Autobahn Therapeutics, Inc. | 2025-03-28 |
| ABX-002 Bioequivalence and Effect of Food Study in Healthy Adult Participants (NCT07652697) | Autobahn Therapeutics, Inc. | 2025-01-02 |
| Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY) (NCT06633016) | Autobahn Therapeutics, Inc. | 2024-09-20 |
| SAD/MAD of ABX-002-1902 Investigating the Safety, Pharmacokinetics/Pharmacodynamics of in Healthy Subjects (NCT05528315) | Autobahn Therapeutics, Inc. | 2022-10-12 |
Track Autobahn Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.